chr10-98423758-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000195.5(HPS1):​c.1527C>G​(p.Leu509Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0115 in 1,614,126 control chromosomes in the GnomAD database, including 405 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L509L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.015 ( 36 hom., cov: 32)
Exomes 𝑓: 0.011 ( 369 hom. )

Consequence

HPS1
NM_000195.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.50

Publications

10 publications found
Variant links:
Genes affected
HPS1 (HGNC:5163): (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]
HPS1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 10-98423758-G-C is Benign according to our data. Variant chr10-98423758-G-C is described in ClinVar as Benign. ClinVar VariationId is 255501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.5 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS1NM_000195.5 linkc.1527C>G p.Leu509Leu synonymous_variant Exon 15 of 20 ENST00000361490.9 NP_000186.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS1ENST00000361490.9 linkc.1527C>G p.Leu509Leu synonymous_variant Exon 15 of 20 1 NM_000195.5 ENSP00000355310.4 Q92902-1
ENSG00000289758ENST00000699159.1 linkn.*886C>G non_coding_transcript_exon_variant Exon 14 of 24 ENSP00000514167.1 A0A8V8TP71
ENSG00000289758ENST00000699159.1 linkn.*886C>G 3_prime_UTR_variant Exon 14 of 24 ENSP00000514167.1 A0A8V8TP71

Frequencies

GnomAD3 genomes
AF:
0.0152
AC:
2310
AN:
152224
Hom.:
36
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0269
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00883
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.0374
Gnomad SAS
AF:
0.0836
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00619
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0168
AC:
4212
AN:
251230
AF XY:
0.0191
show subpopulations
Gnomad AFR exome
AF:
0.0278
Gnomad AMR exome
AF:
0.00457
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.0393
Gnomad FIN exome
AF:
0.000462
Gnomad NFE exome
AF:
0.00536
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.0111
AC:
16191
AN:
1461784
Hom.:
369
Cov.:
33
AF XY:
0.0128
AC XY:
9282
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.0308
AC:
1031
AN:
33480
American (AMR)
AF:
0.00478
AC:
214
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000383
AC:
10
AN:
26136
East Asian (EAS)
AF:
0.0269
AC:
1066
AN:
39700
South Asian (SAS)
AF:
0.0688
AC:
5933
AN:
86250
European-Finnish (FIN)
AF:
0.000825
AC:
44
AN:
53342
Middle Eastern (MID)
AF:
0.00992
AC:
57
AN:
5748
European-Non Finnish (NFE)
AF:
0.00625
AC:
6948
AN:
1112010
Other (OTH)
AF:
0.0147
AC:
888
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1029
2059
3088
4118
5147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0152
AC:
2308
AN:
152342
Hom.:
36
Cov.:
32
AF XY:
0.0157
AC XY:
1168
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0268
AC:
1114
AN:
41590
American (AMR)
AF:
0.00882
AC:
135
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.0373
AC:
193
AN:
5178
South Asian (SAS)
AF:
0.0835
AC:
403
AN:
4828
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00619
AC:
421
AN:
68022
Other (OTH)
AF:
0.0147
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
126
252
377
503
629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00807
Hom.:
4
Bravo
AF:
0.0144
Asia WGS
AF:
0.0700
AC:
244
AN:
3478
EpiCase
AF:
0.00545
EpiControl
AF:
0.00581

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Benign:1
Nov 26, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
5.2
DANN
Benign
0.55
PhyloP100
2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17109850; hg19: chr10-100183515; API